Loading...
$2.1M
Awarded Sep 24, 2026
Competition
FULL AND OPEN COMPETITION
Offers
N/A
Set-Aside
None
Solicitation Type
RFP - Negotiated
Performance Timeline
Start
Sep 30, 2026
Estimated start: Sep 29, 2027
Contract: 75A50126F61014
UEI
Z6N1LJ2RD6E3
Parent Company
SEQIRUS INC
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$2,148,912
Base + Exercised Options
$2,148,912
Total Ceiling Value
$28,689,803
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
Description
MANUFACTURE AND STABILITY STUDIES OF THIMEROSAL-FREE PANDEMIC INFLUENZA VACCINE MULTIDOSE VIALS (MDVS)
NAICS
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 13
Awarding Agency
Top-tier Agency
Office of Assistant Secretary for Preparedness and Response
Sub-tier Agency
BARDA - ASPR / DAAPPO / BARDA DCMA
Office
Funding Agency
Top-tier Agency
Office of Assistant Secretary for Preparedness and Response
Sub-tier Agency
BARDA - ASPR / DAAPPO / BARDA DCMA
Office
Contract Vehicle
75A50122D00004
IDCDepartment of Health and Human Services
Award Type: SINGLE AWARD